Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe Counter Uas Market

ID: MRFR/AD/42748-HCR
128 Pages
Shubham Munde
Last Updated: April 06, 2026

Europe Counter UAS Market Size, Share, Industry Trend & Analysis Research Report By Application (Detection, Interdiction), By Product Type (Radar, RF Scanners, EO/IR, Acoustic System, Combined Sensors, Jammers, Spoofing, Laser, Nets), By End Use (Military Defense, Commercial, Homeland Security), By Technology (Laser System, Kinetic System, Electronic System), By System Configuration (Portable, Vehicle Mounted, Standalone), By Platform (Air, Ground, Naval) and By Purpose (Base Protection, Complimenting Existing Weapons, Airport Airspace Protection, VIP Protection, Counter-Smuggling Operations, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Europe Counter Uas Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Application (USD Million)
      1. 4.1.1 Detection
      2. 4.1.2 Interdiction
    2. 4.2 Pharmaceutical, BY End Use (USD Million)
      1. 4.2.1 Military & Defense
      2. 4.2.2 Commercial
      3. 4.2.3 Homeland Security
    3. 4.3 Pharmaceutical, BY Technology (USD Million)
      1. 4.3.1 Laser System
      2. 4.3.2 Kinetic System
      3. 4.3.3 Electronic System
    4. 4.4 Pharmaceutical, BY System Configuration (USD Million)
      1. 4.4.1 Portable
      2. 4.4.2 Vehicle Mounted
      3. 4.4.3 Standalone
    5. 4.5 Pharmaceutical, BY Platform (USD Million)
      1. 4.5.1 Air
      2. 4.5.2 Ground
      3. 4.5.3 Naval
    6. 4.6 Pharmaceutical, BY Purpose (USD Million)
      1. 4.6.1 Base Protection
      2. 4.6.2 Complimenting Existing Weapons
      3. 4.6.3 Airport Airspace Protection
      4. 4.6.4 VIP Protection
      5. 4.6.5 Counter-Smuggling Operations
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Lockheed Martin (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Northrop Grumman (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Raytheon Technologies (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Thales Group (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Leonardo (IT)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 BAE Systems (GB)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 DroneShield (AU)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 SRC Inc. (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 EUROPE MARKET ANALYSIS BY APPLICATION
    3. 6.3 EUROPE MARKET ANALYSIS BY END USE
    4. 6.4 EUROPE MARKET ANALYSIS BY TECHNOLOGY
    5. 6.5 EUROPE MARKET ANALYSIS BY SYSTEM CONFIGURATION
    6. 6.6 EUROPE MARKET ANALYSIS BY PLATFORM
    7. 6.7 EUROPE MARKET ANALYSIS BY PURPOSE
    8. 6.8 KEY BUYING CRITERIA OF PHARMACEUTICAL
    9. 6.9 RESEARCH PROCESS OF MRFR
    10. 6.10 DRO ANALYSIS OF PHARMACEUTICAL
    11. 6.11 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    12. 6.12 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    13. 6.13 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    20. 6.20 PHARMACEUTICAL, BY SYSTEM CONFIGURATION, 2024 (% SHARE)
    21. 6.21 PHARMACEUTICAL, BY SYSTEM CONFIGURATION, 2024 TO 2035 (USD Million)
    22. 6.22 PHARMACEUTICAL, BY PLATFORM, 2024 (% SHARE)
    23. 6.23 PHARMACEUTICAL, BY PLATFORM, 2024 TO 2035 (USD Million)
    24. 6.24 PHARMACEUTICAL, BY PURPOSE, 2024 (% SHARE)
    25. 6.25 PHARMACEUTICAL, BY PURPOSE, 2024 TO 2035 (USD Million)
    26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY END USE, 2025-2035 (USD Million)
      3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
      4. 7.2.4 BY SYSTEM CONFIGURATION, 2025-2035 (USD Million)
      5. 7.2.5 BY PLATFORM, 2025-2035 (USD Million)
      6. 7.2.6 BY PURPOSE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Europe Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

  • Detection
  • Interdiction

Pharmaceutical By End Use (USD Million, 2025-2035)

  • Military & Defense
  • Commercial
  • Homeland Security

Pharmaceutical By Technology (USD Million, 2025-2035)

  • Laser System
  • Kinetic System
  • Electronic System

Pharmaceutical By System Configuration (USD Million, 2025-2035)

  • Portable
  • Vehicle Mounted
  • Standalone

Pharmaceutical By Platform (USD Million, 2025-2035)

  • Air
  • Ground
  • Naval

Pharmaceutical By Purpose (USD Million, 2025-2035)

  • Base Protection
  • Complimenting Existing Weapons
  • Airport Airspace Protection
  • VIP Protection
  • Counter-Smuggling Operations

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓